Septic shock after liver transplantation for Caroli's disease: Clinical improvement after treatment with C1-esterase inhibitor

Intensive Care Medicine

Volumn 25, Issue 9, 1999, Pages 1017-1020

  Marx, G ^a   Nashan, B ^a   Cobas Meyer, M ^a   Vangerow, B ^a   Schlitt, H J ^a   Ziesing, S ^a   Leuwer, M ^a   Piepenbrock, S ^a   Rueckoldt, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C1 esterase inhibitor; Caroli's disease; Colloid osmotic pressure; Complement system; Liver transplantation; Sepsis

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; FLUCONAZOLE; HYPERTENSIVE FACTOR; MEROPENEM; TOBRAMYCIN; VANCOMYCIN;

ADULT; ARTICLE; CAPILLARY LEAK SYNDROME; CAROLI DISEASE; CASE REPORT; COMPLEMENT ACTIVATION; FATALITY; FEMALE; FLUID BALANCE; HEMODYNAMICS; HUMAN; INTENSIVE CARE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; SEPTIC SHOCK; SURGICAL INFECTION;

ADULT; CAROLI DISEASE; COMPLEMENT C1 INACTIVATOR PROTEINS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; SALVAGE THERAPY; SHOCK, SEPTIC;

EID: 0032847926     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340051000     Document Type: Article

References (10)

1. 1. Hack CE, Ogilvie AC, Eisele B, Eerenberg AJ, Wagstaff J, Thijs LG (1993) C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 19 [Suppl] 1:S19-S28
2. 2. Nuijens J, Eerenberg-Belmer A, Huijbregts C, Schreuder W, Felt-Bersma R, Abbink J, Thijs L, Hack C (1989) Proteolylic inactivalion of plasma C1-inhibitor in sepsis. J Clin Invest 84: 443-450
3. 3. Nurnberger W, Heying H, Burdach S, Göbel U (1997) C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 75: 95-101
4. 4. Landen S, Bardaxoglou E, Maddern GJ, Delugeau V, Gosselin M, Launois B (1993) Caroli's discase: a surgical dilemma. Acta Chir Belg 93: 224-226
5. 5. Sans M, Rimola A, Navasa M, Grande L, Garcia Valdecasas JC, Andreu H, Salmeron JM, Mas A, Rodes J (1997) Liver transplantation in patients with Caroli's disease and recurrent cholangitis. Transpl Int 10: 241-244
6. 6. Schiano TD, Fiel MI, Miller CM, Bodenheimer HC Jr, Min AD (1997) Adult presentation of Caroli's syndrome treated with orthotopic liver transplantation. Am J Gastroenterol 92: 1938-1940
7. 7. Balsells J, Margarit C, Murio E, Lazaro JL, Charco R, Vidal MT, Bonnin J (1993) Adenocarcinorna in Caroli's disease treated by liver transplantation. HPB Surg 7: 81-86
8. 8. Bork K, Kolde H (1986) Angioneurotisches Ödem und andere C1-Inaktivator-Funktionsstörungen: Neue funktionelle Bestimmungsmethode. Diagnose und Labor 36 (8):8-15
9. 9. Vangerow B, Marx G, Leuwer M, Rueckoldt H (1997) C1-Inhibitor-Aktivität, Flüssigkeitsbilanz und 30-Tage Mortalität bei septischen Patienten. Intensivmed 34 [Suppl 1]:49
10. 10. Vangerow B, Marx G, Leuwer M, Rueckoldt H (1998) C1-Inhibitor substitution as ultima ratio therapy in septic shock: experience with 15 patients. Crit Care Med 2 [Suppl 1]:19